Synlogic Receives Orphan Drug Designation from FDA for SYNB1934 for Treatment of Phenylketonuria
CAMBRIDGE, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - May 9, 2023 Category: Pharmaceuticals Source Type: clinical trials
Comparison of Online Group Therapy Interventions for Procrastination
Condition: Procrastination Interventions: Behavioral: Psychoeducation and cognitive modules; Behavioral: Behavioral module: Starting on Time and Planning Realistically; Behavioral: Behavioral module: Working Time Restriction; Behavioral: Behavioral module: Pomodoro Time Management Technique Sponsors: Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of Social Sciences and Humanities, Warsaw; Institute of Psychology, Polish Academy of Sciences; National Science Centre, Poland Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2023 Category: Research Source Type: clinical trials
Comparison of Online Group Therapy Interventions for Procrastination
Condition: Procrastination Interventions: Behavioral: Psychoeducation and cognitive modules; Behavioral: Behavioral module: Starting on Time and Planning Realistically; Behavioral: Behavioral module: Working Time Restriction; Behavioral: Behavioral module: Pomodoro Time Management Technique Sponsors: Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of Social Sciences and Humanities, Warsaw; Institute of Psychology, Polish Academy of Sciences; National Science Centre, Poland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2023 Category: Research Source Type: clinical trials
